Fianlimab (Anti-LAG3 / CD223) | CD markers antibody | Read Reviews & Product Use Citations

Fianlimab (Anti-LAG3 / CD223) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells. It has anti-tumour activity and can be used in treatment of advanced melanoma. MW :145.72 KD.

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Fianlimab (Anti-LAG3 / CD223) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells. It has anti-tumour activity and can be used in treatment of advanced melanoma. MW :145.72 KD.

References
[1] Omid Hamid, et al. Meeting Abstract \| 2021 ASCO Annual Meeting I.

References

[1] Omid Hamid, et al. Meeting Abstract | 2021 ASCO Annual Meeting I.

Product Details

CAS No.	2126132-98-5
Molecular Weight	145.72
Isotype	Human IgG4SP
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field